Skip to main content
AmigoFish

Beyond equity: Why venture debt is reshaping European biotech

From BioSpace · · 22 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

In this episode of Denatured, you’ll hear from Jennifer McMahon, partner at Seroba and Joey Mason, venture partner at Claret Capital. We dig into how venture debt buys time when equity can’t — and how Europe’s funding gaps, tranching habits and slower urgency shape who uses it well.

Host

Jennifer C. Smith-Parker (https://www.linkedin.com/in/jennifersmithparker/), Director of Insights, BioSpace

Guests

Jennifer McMahon (https://www.linkedin.com/in/jennifer-mcmahon-564b6835/), Partner, Seroba

Joey Mason (https://www.linkedin.com/in/joey-mason/), Venture Partner, Claret Capital

Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.

Back to BioSpace · Report a problem